Bibliography

Click here for Printer-friendly bibliography Get Adobe Acrobat
(Adobe Acrobat Required)

Published Manuscripts

  1. Alsayegh F, Kamaliddin H, Sheshah E, Bukhamseen N, Alkhuwaitir T, Elhoufi A. Assessment of venous thromboembolism risk and adequacy of prophylaxis in selected acute care medical centres in Arabian Gulf States: results from the ENDORSE study. Med Princ Pract; 2012;21(6):522-8.
  2. Anderson FA Jr, Goldhaber SZ, Tapson VF, Bergmann JF, Kakkar AK, Deslandes B, Huang W, Cohen AT; ENDORSE Investigators. Improving Practices in US Hospitals to Prevent Venous Thromboembolism: lessons from ENDORSE. AM J Med. 2010 Dec;123(12):1099-1106.e8.
  3. Bergmann JF, Cohen AT, Tapson VF, Goldhaber SZ, Kakkar AK, Deslandes B, Huang W, Anderson FA Jr, for the ENDORSE Investigators. Venous Thromboembolism Risk and Prophylaxis in Hospitalized Medically Ill Patients: The ENDORSE Global Survey. Thromb Haemost. 2010 Mar 31;103(4):736-48.
  4. Bergmann JF, Lloret-Linares C, Rami A, Cohen AT, Garay RP, Kakkar AK, Goldhaber SZ, Deslandes B, Tapson VF, Anderson FA; pour les investigateurs de l’étude Endorse France. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): Results obtained in France. Presse Med. 2011 Sep 30. [Epub ahead of print]
  5. Chopard P, Spirk D, Beer HJ, et al. Swiss results from a global observational study of venous thromboembolism risk and prophylaxis use in the acute care hospital setting: analysis from the ENDORSE study. Swiss Med Wkly 2009 Oct 31;139(43-44):630-5.
  6. Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, Huang W, Zayaruzny M, Emery L, Anderson FA Jr, for the ENDORSE Investigators. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE Study): a multinational cross-sectional study. Lancet 2008 Feb 2;371(9610)387-94.
  7. Dennis RJ, Roa JH, Villadiego J, Méndez F, Vieda E, Restrepo H. Venous thromboembolism prophylaxis in Colombian surgical and medical patients: results for Colombia of the ENDORSE study. Biomedica; 2011 Jun;31(2):200-8.
  8. França A, Reis A, Paulino A, Lohman C, Cartucho D, Campello G, Morais L, Moreira P, Abreu R, Abreu T, ENDORSE Investigators. Venous thromboembolism risk factors and practices of prophylaxis: ENDORSE study results in Portugal. Acta Med Port; 2011 Nov-Dec;24(6):951-60.
  9. Goubran HA, Sholkamy S, El-Haddad A, Mahmoud A, Rizkallah MA, Sobhy G. Venous thromboembolism risk and prophylaxis in the acute hospital care setting: report from the ENDORSE study in Egypt. Thromb J; 2012;10(1):20.
  10. Jerbi Z, Houman MH, Ghedira H, Kamoun S, Ben Salah A. Venous thromboembolism risk and prophylaxis in the acute hospital care setting-results of the ENDORSE study in Tunisia. Med; 2011 Oct;89(10):784-9.
  11. Huang W, Anderson FA, Rushton-Smith SK, Cohen AT. Impact of Thromboprophylaxis across the US Acute Care Setting. PLoS One. 2015 Mar 27;10(3):e0121429. doi: 10.1371/journal.pone.0121429. eCollection 2015.
  12. Kakkar AK, Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Deslandes B, Huang W, Anderson FA Jr, for the ENDORSE Investigators. Venous Thromboembolism Risk and Prophylaxis in the Acute Care Hospital Setting (ENDORSE Survey): Findings in Surgical Patients. Ann Surg. 2010 Feb;251(2):330-8.
  13. Losonczy H, Tar A. [Results of ENDORSE study in Hungary. Multinational, cross-sectional study to assess the prevalence of venous thromboembolism risk and prophylaxis in acute hospital care setting]. Orv Hetil. 2008 Nov 2;149(44):2069-76. Hungarian.
  14. Losonczy H, Tar A. [Results of ENDORSE-2-HUNGARIA study. Repeated assessment of the prevalence of venous thromboembolism risk and prophylaxis in acute hospital care setting.] Orv Hetil. 2010 May 23;151(21):843-52. Hungarian.
  15. Martínez-Zubieta R. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE II study): results of a Mexican national cross-sectional study. Cir Cir. 2010 Jul-Aug;78(4):333-41.
  16. Murphy O, O'Connell O, Liston R, Connaughton J, Costello R, Breiden J, Doran P, Gaine S. Venous thromboembolism risk and prophylaxis in the acute hospital care setting: the Irish results of the ENDORSE study. Ir Med J; 2012 May;105(5):140-3.
  17. Musiał J, Sydor WJ; ENDORSE Investigators-Poland. Venous thromboembolism risk and prophylaxis in the acute hospital care setting--results of the ENDORSE Study in Poland. Pol Arch Med Wewn. 2008 Oct;118(10):555-61.
  18. Nieto Rodríguez JA; ENDORSE.Venous thromboembolism risk and antithrombotic prophylaxis among patients admitted to Spanish hospitals (ENDORSE study)] Med Clin (Barc). 2009 Jun 6;133(1):1-7. Epub 2009 May 15. Spanish.
  19. Ongen G, Yilmaz A, Cirak A, Ersoy C, Erden F, Altintas F, Yildirim C, Güven H, Demir A, Kaynar L, Bastaci N, Demirtas N. Venous Thromboembolism Risk and Thromboprophylaxis Among Hospitalized Patients: Data From the Turkish Arm of the ENDORSE Study. Clin Appl Thromb Hemost. 2011 Oct;17(5):539-45. Epub 2010 Sep 9.
  20. Pinjala R, ENDORSE-India investigators. Venous thromboembolism risk & prophylaxis in the acute hospital care setting (ENDORSE), a multinational cross-sectional study: results from the Indian subset data. Indian J Med Res; 2012 Jul;136(1):60-7.
  21. Zotz RB, Kauschat-Brüning D, Bramlage P; ENDORSE Studienleiter. [Thromboembolic risk and prophylaxis in hospitalized surgical and internal medicine patients. German results of the international ENDORSE Study]. Dtsch Med Wochenschr. 2009 Oct;134(43):2163-9. Epub 2009 Oct 13. German.

Abstracts

  1. Cohen A.T., Tapson V.F., Bergmann J.F., Goldhaber S.Z., Kakkar A.K, Anderson F.A., for the ENDORSE Investigators. Late breaking clinical trial: a large-scale, global observational study of venous thromboembolism risk and prophylaxis in the acute hospital care setting: the endorse study. Overview abstract presented at ISTH meeting in Geneva July 8, 2007